These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29259802)

  • 1. The effect of the GLP-1 analogue Exenatide on functional connectivity within an NTS-based network in women with and without obesity.
    Coveleskie K; Kilpatrick LA; Gupta A; Stains J; Connolly L; Labus JS; Sanmiguel C; Mayer EA
    Obes Sci Pract; 2017 Dec; 3(4):434-445. PubMed ID: 29259802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of GLP-1 receptor agonist treatment on body weight in obese antipsychotic-treated patients with schizophrenia: a randomized, placebo-controlled trial.
    Ishøy PL; Knop FK; Broberg BV; Bak N; Andersen UB; Jørgensen NR; Holst JJ; Glenthøj BY; Ebdrup BH
    Diabetes Obes Metab; 2017 Feb; 19(2):162-171. PubMed ID: 27717222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity medication lorcaserin activates brainstem GLP-1 neurons to reduce food intake and augments GLP-1 receptor agonist induced appetite suppression.
    Wagner S; Brierley DI; Leeson-Payne A; Jiang W; Chianese R; Lam BYH; Dowsett GKC; Cristiano C; Lyons D; Reimann F; Gribble FM; Martinez de Morentin PB; Yeo GSH; Trapp S; Heisler LK
    Mol Metab; 2023 Feb; 68():101665. PubMed ID: 36592795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome.
    Sze L; Purtell L; Jenkins A; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
    J Clin Endocrinol Metab; 2011 Aug; 96(8):E1314-9. PubMed ID: 21632815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics.
    Lee A; Patrick P; Wishart J; Horowitz M; Morley JE
    Diabetes Obes Metab; 2002 Sep; 4(5):329-35. PubMed ID: 12190996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.
    van Bloemendaal L; IJzerman RG; Ten Kulve JS; Barkhof F; Konrad RJ; Drent ML; Veltman DJ; Diamant M
    Diabetes; 2014 Dec; 63(12):4186-96. PubMed ID: 25071023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with exenatide decreases the dapagliflozin-induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trial.
    van Ruiten CC; Veltman DJ; Wijdeveld M; Ten Kulve JS; Kramer MHH; Nieuwdorp M; IJzerman RG
    Diabetes Obes Metab; 2022 Aug; 24(8):1588-1597. PubMed ID: 35491524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of sucrose ingestion on brainstem and hypothalamic intrinsic oscillations in lean and obese women.
    Kilpatrick LA; Coveleskie K; Connolly L; Labus JS; Ebrat B; Stains J; Jiang Z; Suyenobu BY; Raybould HE; Tillisch K; Mayer EA
    Gastroenterology; 2014 May; 146(5):1212-21. PubMed ID: 24480616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resting-state functional connectivity of brain regions involved in cognitive control, motivation, and reward is enhanced in obese females.
    Lips MA; Wijngaarden MA; van der Grond J; van Buchem MA; de Groot GH; Rombouts SA; Pijl H; Veer IM
    Am J Clin Nutr; 2014 Aug; 100(2):524-31. PubMed ID: 24965310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exenatide has a pronounced effect on energy intake but not energy expenditure in non-diabetic subjects with obesity: A randomized, double-blind, placebo-controlled trial.
    Basolo A; Burkholder J; Osgood K; Graham A; Bundrick S; Frankl J; Piaggi P; Thearle MS; Krakoff J
    Metabolism; 2018 Aug; 85():116-125. PubMed ID: 29596853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity is marked by distinct functional connectivity in brain networks involved in food reward and salience.
    Wijngaarden MA; Veer IM; Rombouts SA; van Buchem MA; Willems van Dijk K; Pijl H; van der Grond J
    Behav Brain Res; 2015; 287():127-34. PubMed ID: 25779924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPG neurons in the nucleus of the solitary tract modulate heart rate but do not mediate GLP-1 receptor agonist-induced tachycardia in mice.
    Holt MK; Cook DR; Brierley DI; Richards JE; Reimann F; Gourine AV; Marina N; Trapp S
    Mol Metab; 2020 Sep; 39():101024. PubMed ID: 32446875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide to Characterize Its Antiobesity Effects in Diet-Induced Obese Mice.
    Iwasaki S; Hamada T; Chisaki I; Andou T; Sano N; Furuta A; Amano N
    J Pharmacol Exp Ther; 2017 Sep; 362(3):441-449. PubMed ID: 28698254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locally delivered GLP-1 analogues liraglutide and exenatide enhance microvascular perfusion in individuals with and without type 2 diabetes.
    Aung MM; Slade K; Freeman LAR; Kos K; Whatmore JL; Shore AC; Gooding KM
    Diabetologia; 2019 Sep; 62(9):1701-1711. PubMed ID: 31203378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Dapagliflozin and Combination Therapy With Exenatide on Food-Cue Induced Brain Activation in Patients With Type 2 Diabetes.
    van Ruiten CC; Veltman DJ; Schrantee A; van Bloemendaal L; Barkhof F; Kramer MHH; Nieuwdorp M; IJzerman RG
    J Clin Endocrinol Metab; 2022 May; 107(6):e2590-e2599. PubMed ID: 35134184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous GLP-1 alters postprandial functional connectivity between homeostatic and reward-related brain regions involved in regulation of appetite in healthy lean males: A pilotstudy.
    Meyer-Gerspach AC; Ly HG; Borgwardt S; Dupont P; Beglinger C; Van Oudenhove L; Wölnerhanssen BK
    Diabetes Obes Metab; 2018 Oct; 20(10):2330-2338. PubMed ID: 29790260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exenatide Regulates Cerebral Glucose Metabolism in Brain Areas Associated With Glucose Homeostasis and Reward System.
    Daniele G; Iozzo P; Molina-Carrion M; Lancaster J; Ciociaro D; Cersosimo E; Tripathy D; Triplitt C; Fox P; Musi N; DeFronzo R; Gastaldelli A
    Diabetes; 2015 Oct; 64(10):3406-12. PubMed ID: 26116695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial.
    Farr OM; Sofopoulos M; Tsoukas MA; Dincer F; Thakkar B; Sahin-Efe A; Filippaios A; Bowers J; Srnka A; Gavrieli A; Ko BJ; Liakou C; Kanyuch N; Tseleni-Balafouta S; Mantzoros CS
    Diabetologia; 2016 May; 59(5):954-65. PubMed ID: 26831302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating appetite/satiety hormones and eating behaviours as predictors of weight loss maintenance with GLP-1RA therapy in adolescents with severe obesity.
    Bensignor MO; Kelly AS; Kunin-Batson A; Fox CK; Freese R; Clark J; Rudser KD; Bomberg EM; Ryder J; Gross AC
    Pediatr Obes; 2024 May; 19(5):e13105. PubMed ID: 38339799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cine gastric MRI reveals altered Gut-Brain Axis in Functional Dyspepsia: gastric motility is linked with brainstem-cortical fMRI connectivity.
    Sclocco R; Fisher H; Staley R; Han K; Mendez A; Bolender A; Coll-Font J; Kettner NW; Nguyen C; Kuo B; Napadow V
    Neurogastroenterol Motil; 2022 Oct; 34(10):e14396. PubMed ID: 35560690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.